Document is current
Any future updates will be listed below
-
Authors
Blum, Alex C.
Tessema, Rachael
Nussbaum, Lauren
Hidalgo, Cristina
López, E. Jennifer Ríos
Sánchez, Graciela Meza
Morse, Rachel M.
Brown, Joanna
Reategui, Reyles Ríos
Wong, Lucía
Córdova, Luis Díaz
Díaz, Karina Gonzales
Liñán, Renso López
Vásquez, Javier Vásquez
Tracy, J. Kathleen
Paz-Soldan, Valerie A.
-
Funding
Funding for this research was provided by:
NIH Fogarty International Center (D43TW009340)
Tulane Program to Advance Representation in Minority Health Research (T37 MD001424)
National Institute of Health/National Cancer Institute (U01-CA190366, U01-CA190366, U01-CA190366, U01-CA190366, U01-CA190366, U01-CA190366, U01-CA190366, U01-CA190366)
- License Information
-
More Information
Article History
Received: 9 September 2024
Accepted: 1 April 2025
First Online: 14 April 2025
Declarations
:
: Our study adhered to the Declaration of Helsinki. Ethics approval for this study was obtained from the institutional review boards at: Asociación Benéfica PRISMA (CE0251.09), Tulane University School of Public Health and Tropical Medicine (reference number 891039), the University of Maryland School of Medicine (IRB#061614), Hospital Regional Loreto (ID- 002-CIEI- 2017), and Hospital Apoyo Iquitos (065-ID-ETHICS COMMITTEE HICGG- 2018). As approved by these IRB committees, all participants provided verbal and written informed consent to participate.
: Not applicable.
: V.P.S., on behalf of the Proyecto Precancer, received discounted prices and/or donated supplies from Copan and Cepheid. The authors declare that they have no other competing interests.
